Nanalysis Scientific Corp.
OTC:NSCIF
0.3189 (USD) • At close November 15, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
---|---|---|---|---|---|---|---|---|
Assets: | ||||||||
Current Assets: | ||||||||
Cash & Cash Equivalents
| 0.759 | 3.525 | 10.405 | 3.158 | 6.619 | 0.779 | 0.686 | 0.072 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 0.759 | 3.525 | 10.405 | 3.158 | 6.619 | 0.779 | 0.686 | 0.072 |
Net Receivables
| 9.758 | 8.983 | 6.1 | 3.045 | 2.561 | 4.011 | 1.553 | 0 |
Inventory
| 5.794 | 7.387 | 3.679 | 2.83 | 0.857 | 0.735 | 0.673 | 1.015 |
Other Current Assets
| 1.603 | 2.06 | 0.578 | 0.319 | 0.128 | 0.034 | 0.005 | 0.007 |
Total Current Assets
| 17.914 | 21.955 | 20.762 | 9.352 | 10.165 | 5.559 | 0.691 | 0.079 |
Non-Current Assets: | ||||||||
Property, Plant & Equipment, Net
| 4.737 | 6.424 | 2.539 | 1.95 | 1.634 | 1.136 | 0.624 | 0.665 |
Goodwill
| 5.696 | 13.083 | 0.385 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 15.946 | 26.627 | 14.107 | 12.687 | 6.487 | 4.233 | 0.38 | 0.344 |
Goodwill and Intangible Assets
| 21.642 | 39.71 | 14.492 | 12.687 | 6.487 | 4.233 | 0.38 | 0.344 |
Long Term Investments
| 6.42 | 0.77 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0.104 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 3.111 | 0.939 | 0 | 0 | 0.02 | 0.02 | 2.535 | 2.196 |
Total Non-Current Assets
| 35.91 | 47.947 | 17.031 | 14.637 | 8.141 | 5.389 | 3.539 | 3.205 |
Total Assets
| 53.824 | 69.902 | 37.793 | 23.989 | 18.306 | 10.948 | 0.691 | 0.079 |
Liabilities & Equity: | ||||||||
Current Liabilities: | ||||||||
Account Payables
| 5.081 | 5.759 | 4.441 | 2.619 | 0.678 | 1.03 | 1.154 | 0.861 |
Short Term Debt
| 7.286 | 4.44 | 2.198 | 0.434 | 0.248 | 0.233 | 0.646 | 0.487 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 1.321 | 1.932 | 1.798 | 2.868 | 0.616 | 0.316 | -1.8 | -1.348 |
Other Current Liabilities
| 0.908 | 1.375 | 0.209 | 0.382 | 0.089 | 0.178 | 0.059 | 0.004 |
Total Current Liabilities
| 14.596 | 13.506 | 8.646 | 6.303 | 1.631 | 1.757 | 0.059 | 0.004 |
Non-Current Liabilities: | ||||||||
Long Term Debt
| 12.557 | 6.313 | 3.787 | 3.342 | 1.259 | 0.764 | 0.858 | 0.882 |
Deferred Revenue Non-Current
| 0.881 | 1.117 | 0.822 | 0.668 | 1.02 | -0.036 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0.184 | 0.256 | 0.258 | 2.147 | 0.297 | 0.036 | 0 | 0 |
Other Non-Current Liabilities
| 2.125 | 1.138 | 0.319 | -2.815 | -1.02 | 0.036 | 0 | 0 |
Total Non-Current Liabilities
| 15.747 | 8.824 | 5.186 | 3.342 | 1.556 | 0.8 | 0.858 | 0.882 |
Total Liabilities
| 30.343 | 22.33 | 13.832 | 9.645 | 3.187 | 2.557 | 0.059 | 0.004 |
Equity: | ||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 53.201 | 49.016 | 31.295 | 20.665 | 18.267 | 9.976 | 0.761 | 0.101 |
Retained Earnings
| -34.989 | -18.793 | -9.692 | -7.92 | -4.242 | -2.582 | -0.197 | -0.025 |
Accumulated Other Comprehensive Income/Loss
| 0.596 | 0.969 | 0.165 | 0.215 | 0 | -0 | 0.067 | 0.715 |
Other Total Stockholders Equity
| 4.673 | 3.938 | 2.193 | 1.384 | 1.094 | 0.997 | 0 | -0.715 |
Total Shareholders Equity
| 23.481 | 35.13 | 23.961 | 14.344 | 15.119 | 8.391 | 0.631 | 0.075 |
Total Equity
| 23.481 | 47.572 | 23.961 | 14.344 | 15.119 | 8.391 | 0.631 | 0.075 |
Total Liabilities & Shareholders Equity
| 53.824 | 69.902 | 37.793 | 23.989 | 18.306 | 10.948 | 0.691 | 0.079 |